Steven Neema Seyedin, Mira Semaan, Amanda Macaraeg, Ali Raad, Kevin R. Reyes, Suzanne Dufault, Mamta Parikh, Dimitrios Stefanoudakis, Alexandra Drakaki, Neda Hashemi-Sadraei, Zachariah Thomas, Cindy Y. Jiang, Matthew T. Campbell, Omar Alhalabi, Terence W. Friedlander, Vadim S. Koshkin, Nataliya Mar. "Concurrent use of angiotensin-converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB) in patients (pts) with advanced urothelial carcinoma (UC) receiving enfortumab vedotin (EV) plus pembrolizumab (P) therapy.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.759